Daily Digest

Thursday, 24 September 2026

This dated roundup collects the most interesting AI and technology developments found for Thursday, 24 September 2026.

4 min read • Published from the latest available digest

Policy & Ethics

Annovis taps Weave Bio’s AI to speed FDA submission for Alzheimer’s drug

Annovis announced a collaboration with Weave Bio to use the AI regulatory platform for drafting, reviewing and managing New Drug Application documents as the company prepares an NDA for buntanetap. Under the arrangement, Annovis’ regulatory and clinical teams will retain full responsibility for content, verification and final approval of every document submitted to the U.S. […] The post Annovis taps Weave Bio’s AI to speed FDA submission for Alzheimer’s drug appeared first on Longevity.Technology .

Read more

Research & Products

Google launches Gemini 3.8 Flash TTS voice models

Google has launched two Gemini 3.8 Flash TTS voice models, introducing dedicated speech generation systems engineered for direct performance scripting and high-volume audio production. The dual release splits vocal synthesis tasks between creative direction and cost-managed infrastructure. Gemini 3.8 Flash TTS targets interactive entertainment, game development, and long-form narrations where studio teams demand prompt-based vocal […] The post Google launches Gemini 3.8 Flash TTS voice models appeared first on AI News .

Read more

Australia launches investigation after OpenAI agent hacked healthcare database

Prime minister says he told Sam Altman he was disappointed it had taken OpenAI ‘way too long’ to disclose breach Anthony Albanese says an artificial intelligence agent developed by OpenAI hacked Medicare in June and the tech giant notified the government earlier this month using an email sent to a “public mailbox”. Australia’s prime minister made the comments at the UN summit in New York, saying it appeared no personal information had been accessed in the AI breach. Continue reading...

Read more

Industry

Circular Genomics, Altoida partner on multimodal Alzheimer’s testing

Circular Genomics and Altoida announced a collaboration to combine Circular Genomics’ blood-based circular RNA biomarker platform with Altoida’s AI-powered Digital NeuroMarker platform to develop a multimodal approach for Alzheimer’s drug development and frontline care. The alliance aims to pair objective digital measures of cognition and function with blood-based molecular signatures to improve early identification, patient […] The post Circular Genomics, Altoida partner on multimodal Alzheimer’s testing appeared first on Longevity.Technology .

Read more

Tags: ai_agents

Tags: hardware

This digest was automatically generated • 4 min read